Domov › Limfom › New York

Klinične študije za Limfom v New York

42 študij za Limfom išče udeležence na lokacijah v New York.

Mesta v New York

Uradno besedilo študije (angleško)

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

Memorial Sloan Kettering Cancer Center, New York

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07192471

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Roswell Park Comprehensive Cancer Center, Buffalo
Memorial Sloan Kettering Cancer Center, New York

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07015242

Epco, Zanu, Ritux for R/R FL or MZL

Memorial Sloan Kettering Cancer Center, New York

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06563596

Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, East White Plains
Memorial Sloan Kettering Cancer Center, New York
in še 1

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT02974647

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
Memorial Sloan Kettering Cancer Center, New York
in še 1

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT04301076

Collection of Tissue Samples for Cancer Research

Roswell Park Cancer Institute, Buffalo

Vključevanje udeležencevOpazovalna študija

2 Months · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT00900198

Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

Cornell, New York

Vključevanje udeležencevFaza 1

Starost 18–100 · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT05798897

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

Research Site, New York

Vključevanje udeležencevFaza 1/2

Starost 12 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT06137144

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

Roswell Park Cancer Institute, Buffalo
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Memorial Sloan Kettering Cancer Center, New York
in še 1

Vključevanje udeležencevFaza 1/2

12 Months – 21 Years · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT04870944

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

Research Site, Rochester

Vključevanje udeležencevFaza 3

Starost 18–18 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT07509151

A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Stony Brook Univ Cancer Ctr, Stony Brook

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06624085

TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

Memorial Sloan Kettering Cancer Center, New York
Weill Cornell Medicine - New York Presbyterian Hospital, New York

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT07082803

A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

Hematology Oncology Associates of Central New York, East Syracuse
University of Rochester, Rochester
Stony Brook University Hospital Cancer Center, Stony Brook

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06084936

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Roswell Park Comprehensive Cancer Center, Buffalo
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Montefiore Medical Center, The Bronx

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT05826535

A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

Memorial Sloan Kettering Suffolk- Commack (Limited protocol activities), Commack
Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison
Memorial Sloan Kettering Cancer Center, New York
in še 1

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 10. avg. 2026 · NCT05389293

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

New York Medical College, Valhalla

Vključevanje udeležencevFaza 1/2

Starost 13–90 · Vsi spoli · Posodobljeno 6. avg. 2026 · NCT06533579

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Roswell Park Comprehensive Cancer Center, Buffalo

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 4. avg. 2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

Memorial Sloan Kettering Cancer Center, New York

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 13. jul. 2026 · NCT04792489

A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)

Memorial Sloan Kettering, New York

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 8. jul. 2026 · NCT07465835

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

Call for Information (Investigational Site 0031), New York

Vključevanje udeležencevFaza 1/2

6 Months – 17 Years · Vsi spoli · Posodobljeno 6. jul. 2026 · NCT02332668

CD4CAR for CD4+ Leukemia and Lymphoma

Albert Einstein Health Network, New York

Vključevanje udeležencevFaza 1

Starost 12 in več · Vsi spoli · Posodobljeno 24. jun. 2026 · NCT03829540

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Dren Investigational Site 1, New York
Dren Investigational Site 2, New York

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 17. jun. 2026 · NCT05475925

A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)

Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering at Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
in še 1

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 5. jun. 2026 · NCT07137494

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

Mount Sinai Hospital, New York
Memorial Sloan Kettering Cancer Center, New York

Vključevanje udeležencevOpazovalna študija

Starost 18 in več · Vsi spoli · Posodobljeno 1. jun. 2026 · NCT05663502

Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)

Columbia University Irving Medical Center, New York

Vključevanje udeležencevFaza 2

Starost 15 in več · Vsi spoli · Posodobljeno 27. maj 2026 · NCT06954805

A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties

Memorial Sloan Kettering Cancer Center Suffolk - Commack (All protocol activities), Commack
Memorial Sloan Kettering Westchester (All protocol activities), Harrison
Memorial Sloan Kettering Cancer Center (All protocol activities), New York
in še 1

Vključevanje udeležencevVabljeni zdravi prostovoljci

Starost 18 in več · Vsi spoli · Posodobljeno 26. maj 2026 · NCT07052916

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
University of Rochester, Rochester
Stony Brook University Medical Center, Stony Brook
in še 1

Vključevanje udeležencevOpazovalna študija

Vse starosti · Vsi spoli · Posodobljeno 18. maj 2026 · NCT01790152

Cord Blood Transplantation in Children and Young Adults With Blood Cancer

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

Vključevanje udeležencevFaza 2

Do 26 let · Vsi spoli · Posodobljeno 14. maj 2026 · NCT07566377

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Roswell Park Comprehensive Cancer Center, Buffalo
Mt Sinai, New York
Memorial Sloan Kettering Cancer Center, New York

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 16. apr. 2026 · NCT03328078

Study of CAR-T Therapy in Older Patients

Memorial Sloan Kettering Cancer Center, New York

Vključevanje udeležencevOpazovalna študija

Starost 60 in več · Vsi spoli · Posodobljeno 7. apr. 2026 · NCT04300998

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Memorial Sloan Kettering, New York

Vključevanje udeležencevFaza 2

Starost 18–66 · Vsi spoli · Posodobljeno 17. mar. 2026 · NCT06859424

Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy

Icahn School of Medicine at Mount Sinai, New York

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 13. mar. 2026 · NCT06510361

A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1

Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (All protocol activities), Commack
Memorial Sloan Kettering Westchester (All protocol activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
in še 1

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 5. mar. 2026 · NCT06698003